These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 14688102

  • 1. Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein.
    Soe S, Theisen M, Roussilhon C, Aye KS, Druilhe P.
    Infect Immun; 2004 Jan; 72(1):247-52. PubMed ID: 14688102
    [Abstract] [Full Text] [Related]

  • 2. Plasmodium falciparum merozoite surface antigen-specific cytophilic IgG and control of malaria infection in a Beninese birth cohort.
    Adamou R, Dechavanne C, Sadissou I, d'Almeida T, Bouraima A, Sonon P, Amoussa R, Cottrell G, Le Port A, Theisen M, Remarque EJ, Longacre S, Moutairou K, Massougbodji A, Luty AJF, Nuel G, Migot-Nabias F, Sanni A, Garcia A, Milet J, Courtin D.
    Malar J; 2019 Jun 11; 18(1):194. PubMed ID: 31185998
    [Abstract] [Full Text] [Related]

  • 3. Humoral immune response to Plasmodium falciparum vaccine candidate GMZ2 and its components in populations naturally exposed to seasonal malaria in Ethiopia.
    Mamo H, Esen M, Ajua A, Theisen M, Mordmüller B, Petros B.
    Malar J; 2013 Feb 05; 12():51. PubMed ID: 23383869
    [Abstract] [Full Text] [Related]

  • 4. Natural antibody responses to Plasmodium falciparum MSP3 and GLURP(R0) antigens are associated with low parasite densities in malaria patients living in the Central Region of Ghana.
    Amoah LE, Nuvor SV, Obboh EK, Acquah FK, Asare K, Singh SK, Boampong JN, Theisen M, Williamson KC.
    Parasit Vectors; 2017 Aug 23; 10(1):395. PubMed ID: 28835262
    [Abstract] [Full Text] [Related]

  • 5. Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness.
    Stanisic DI, Richards JS, McCallum FJ, Michon P, King CL, Schoepflin S, Gilson PR, Murphy VJ, Anders RF, Mueller I, Beeson JG.
    Infect Immun; 2009 Mar 23; 77(3):1165-74. PubMed ID: 19139189
    [Abstract] [Full Text] [Related]

  • 6. Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa.
    Nebie I, Diarra A, Ouedraogo A, Soulama I, Bougouma EC, Tiono AB, Konate AT, Chilengi R, Theisen M, Dodoo D, Remarque E, Bosomprah S, Milligan P, Sirima SB.
    Infect Immun; 2008 Feb 23; 76(2):759-66. PubMed ID: 18070896
    [Abstract] [Full Text] [Related]

  • 7. Cytophilic immunoglobulin responses to Plasmodium falciparum glutamate-rich protein are correlated with protection against clinical malaria in Dielmo, Senegal.
    Oeuvray C, Theisen M, Rogier C, Trape JF, Jepsen S, Druilhe P.
    Infect Immun; 2000 May 23; 68(5):2617-20. PubMed ID: 10768952
    [Abstract] [Full Text] [Related]

  • 8. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
    Perraut R, Varela ML, Joos C, Diouf B, Sokhna C, Mbengue B, Tall A, Loucoubar C, Touré A, Mercereau-Puijalon O.
    Vaccine; 2017 Dec 04; 35(48 Pt B):6720-6726. PubMed ID: 29042203
    [Abstract] [Full Text] [Related]

  • 9. Plasmodium falciparum malaria in children aged 0-2 years: the role of foetal haemoglobin and maternal antibodies to two asexual malaria vaccine candidates (MSP3 and GLURP).
    Kangoye DT, Nebie I, Yaro JB, Debe S, Traore S, Ouedraogo O, Sanou G, Soulama I, Diarra A, Tiono A, Marsh K, Sirima SB, Bejon P.
    PLoS One; 2014 Dec 04; 9(9):e107965. PubMed ID: 25238160
    [Abstract] [Full Text] [Related]

  • 10. Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children.
    Dodoo D, Aikins A, Kusi KA, Lamptey H, Remarque E, Milligan P, Bosomprah S, Chilengi R, Osei YD, Akanmori BD, Theisen M.
    Malar J; 2008 Jul 29; 7():142. PubMed ID: 18664257
    [Abstract] [Full Text] [Related]

  • 11. Antibody levels against GLURP R2, MSP1 block 2 hybrid and AS202.11 and the risk of malaria in children living in hyperendemic (Burkina Faso) and hypo-endemic (Ghana) areas.
    Adu B, Cherif MK, Bosomprah S, Diarra A, Arthur FK, Dickson EK, Corradin G, Cavanagh DR, Theisen M, Sirima SB, Nebie I, Dodoo D.
    Malar J; 2016 Feb 27; 15():123. PubMed ID: 26921176
    [Abstract] [Full Text] [Related]

  • 12. Age-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican children.
    Dobaño C, Quelhas D, Quintó L, Puyol L, Serra-Casas E, Mayor A, Nhampossa T, Macete E, Aide P, Mandomando I, Sanz S, Puniya SK, Singh B, Gupta P, Bhattacharya A, Chauhan VS, Aponte JJ, Chitnis CE, Alonso PL, Menéndez C.
    Clin Vaccine Immunol; 2012 Feb 27; 19(2):157-66. PubMed ID: 22169088
    [Abstract] [Full Text] [Related]

  • 13. Acquisition of antibodies to merozoite surface protein 3 among residents of Korogwe, north eastern Tanzania.
    Segeja MD, Mmbando BP, Seth MD, Lusingu JP, Lemnge MM.
    BMC Infect Dis; 2010 Mar 08; 10():55. PubMed ID: 20205959
    [Abstract] [Full Text] [Related]

  • 14. Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3.
    Roussilhon C, Oeuvray C, Müller-Graf C, Tall A, Rogier C, Trape JF, Theisen M, Balde A, Pérignon JL, Druilhe P.
    PLoS Med; 2007 Nov 13; 4(11):e320. PubMed ID: 18001147
    [Abstract] [Full Text] [Related]

  • 15. Effect of hookworm infection and anthelmintic treatment on naturally acquired antibody responses against the GMZ2 malaria vaccine candidate and constituent antigens.
    Amoani B, Gyan B, Sakyi SA, Abu EK, Nuvor SV, Barnes P, Sarkodie-Addo T, Ahenkorah B, Sewor C, Dwomoh D, Theisen M, Cappello M, Wilson MD, Adu B.
    BMC Infect Dis; 2021 Apr 08; 21(1):332. PubMed ID: 33832450
    [Abstract] [Full Text] [Related]

  • 16. Naturally acquired antibody responses to Plasmodium falciparum merozoite surface protein 4 in a population living in an area of endemicity in Vietnam.
    Wang L, Richie TL, Stowers A, Nhan DH, Coppel RL.
    Infect Immun; 2001 Jul 08; 69(7):4390-7. PubMed ID: 11401978
    [Abstract] [Full Text] [Related]

  • 17. Comparative analysis of the profiles of IgG subclass-specific responses to Plasmodium falciparum apical membrane antigen-1 and merozoite surface protein-1 in naturally exposed individuals living in malaria hypoendemic settings, Iran.
    Rouhani M, Zakeri S, Mehrizi AA, Djadid ND.
    Malar J; 2015 Feb 05; 14():58. PubMed ID: 25652589
    [Abstract] [Full Text] [Related]

  • 18. Antibody Correlates of Protection from Clinical Plasmodium falciparum Malaria in an Area of Low and Unstable Malaria Transmission.
    Hamre KES, Ondigo BN, Hodges JS, Dutta S, Theisen M, Ayodo G, John CC.
    Am J Trop Med Hyg; 2020 Dec 05; 103(6):2174-2182. PubMed ID: 33124533
    [Abstract] [Full Text] [Related]

  • 19. Antibody responses to P. falciparum blood stage antigens and incidence of clinical malaria in children living in endemic area in Burkina Faso.
    Cherif MK, Ouédraogo O, Sanou GS, Diarra A, Ouédraogo A, Tiono A, Cavanagh DR, Michael T, Konaté AT, Watson NL, Sanza M, Dube TJT, Sirima SB, Nebié I.
    BMC Res Notes; 2017 Sep 08; 10(1):472. PubMed ID: 28886727
    [Abstract] [Full Text] [Related]

  • 20. The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis.
    Fowkes FJ, Richards JS, Simpson JA, Beeson JG.
    PLoS Med; 2010 Jan 19; 7(1):e1000218. PubMed ID: 20098724
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.